Course IC 29 – Cross-Linking – Vinciguerra - 1
XXXI Congress of the ESCRS
5 - 9 October, 2013
Amsterdam, The Netherlands
Course IC 29
Successful Cross-Linking: Managing Complications,
Pediatric Patients, Post-Refractive Surgery Ectasia,
Thin Corneas and Long-Term Follow-Up (EBO Accredited)
Senior Instructor: Paolo Vinciguerra, MD
Associate Instructors:
Jorge L. Alio, MD Leonardo Mastropasqua, MD Fabrizio I. Camesasca, MD
6 October 2013 8.00 – 10.00
Course IC 29 – Cross-Linking – Vinciguerra - 2
INDEX
I. Cross-Linking Safety Measures Fabrizio I. Camesasca, MD
Page 3
II. Cross-Linking Long-Term Outcomes and Age Groups Paolo Vinciguerra, MD
Page 5
III. Simoultaneous Custom Ablation and Cross-Linking Paolo Vinciguerra, MD
Page 8
ADDRESSES ............................................................................................................................. Page 19
Course IC 29 – Cross-Linking – Vinciguerra - 3
I. Cross-Linking Safety Measures
CXL: Safety Measures
Fabrizio I. Camesasca, MD
Paolo Vinciguerra, MD
Silvia Trazza, Orthoptist
Istituto Clinico Humanitas
University of Milan , Italy
Safety Measures 1. Prevention of infections
2. Incorrect vs. correct applications: maps and
OCT
3. Complications due to technical error:
1. Inadequate impregnation
2. Incorrect focusing
3. Home‐made solutions
4. Insufficient hydration
4. Inadequate follow up
Safety Measures Prevention of Infections
• When the epithelium is removed, corneal defences are
hampered
• During epithelial healing cornea is vulnerable to
infections
• Ten reports in literature (Step epi, Escherichia Coli, etc.)
• Pursue sterile conditions
• Postop therapy similar to refractive surgery
• Daily check of patients until reepithelialization
• Provide adequate hygiene instructions !
Safety Measures
Incorrect vs. Correct Applications
• Preventing unnecessary failures
• Adequate patient selection
• Anatomical features: use of
maps and OCT
Corneal opacity: no CXL !! Severe corneal opacities
Age: are older pts bad candidates?
No magic answer Like in every pt: look at
progression No progression: no treatment is
needed
Progression: why let the cornea worsen ?
Fluctuation of area/power of KC from 1°examination to pre CXL in 67 year‐old patient
6 mos later 12mos later
1°examination 2°examination 3°examination
Differential map + 6.36 D in 1 yr
Fluctuation of pachymetry of KC from 1°examination to pre CXL in 67 year‐old patient
6 mos later 12 mos later
1°examination 2°examination 3°examination
Differential Pachimetry map ‐70 microns in 1 yr
Progression KC: 72‐yrs old! Keratoconus: post CXL transition line over time in different pts
83µ
TE CXL
1 day post cxl te
340μ in cornea
292μ in cornea
2007 2008 2009
1 yrs post cxl
2 yrs post cxl
160µ
1 days post cxl te
404μ in cornea 328μ in cornea
144µ
2 days post cxl te
+1,2 d
+2,58 d
3 yrs post cxl
3,5 yrs post cxl
Course IC 29 – Cross-Linking – Vinciguerra - 4
2 3 4 5
Pachimetria
Pachimetria 470,77 406,85 345,58 427,77 452,67
Pachimetria
[email protected] press, Journal of Refractive
mic
rons
1. Intraoperative Pachimetry Opacity and Corneal Edema post CXL Safety Measures
490 470 450 430 410 390
370 350 330 310
470,77
-13.41%
406,85
345,58
427,77
452,67 -3.84%
453 pts
Complications due to technical errors
1. Incorrect focusing / irradiation
2. Inadequate impregnation 290 270 250
-28.94% +5.14%
-15.05 % +9.13 %
1 p<0.001 p<0.001 p<0.001 p>0.2
3. Insufficient hydration
Pre op Sine epi 20 min espans Fine UVA 4. Home‐made solutions
1. Incorrect Focusing
• Corneal Burns
• Erroneous UV calibration
• Inadequate UV focusing
• Distance: verify regularly
• UV rays: orthogonal to iris plane
1. Incorrect Focusing • Corneal Burns
• Riboflavin shield effect:
• reduces gradually UV power (3.0 mW/cm2)
down to 3% of irradiance at 400 μ of
corneal thickness (0.09 mW/cm2)
2. Inadequate Impregnation • Insufficient: reduced shield
• Prolonged: shield not increased below 3%,
induced dehydration with secondary thinning
Corneal Burn: Oblique Irradiation
Marked flattening
Day 5, RE
Corneal Burn: Excessive Flattening
PRE CXL OD BSCVA: 0.8 ‐1,25@94
POST CXL OD BSCVA: 0.6 +7,00 ‐1,00@90
3. Insufficient Hydration
• Delay in Reepithelialization
• Poor application of selection criteria
• Metabolic diseases (diabetes, hypothyroidism)
• Dry eye
• Stem cell insufficiency
• Steep corneas
‐ tear film rupture
• Insufficient corneal hydration during irradiation
(4% hyaluronic acid)
Delay in Reepithelialization
due to corneal burn
6 mos: disappearence of flattening and hyperopia [email protected] [email protected]
Helping Reepithelialization
•Contact lens
• adequate ray of curvature in very
steep corneas
• careful application, massage, check
position
• Aminoacids pre‐load
Conclusions
• Cross‐Linking is a
generally very safe
procedure
• Beware of technical
errors ! [email protected]
Course IC 29 – Cross-Linking – Vinciguerra - 5
VIN
CIE
YE
II. Cross-Linking Long-Term Outcomes and Age Groups
CXL PAPERS PHASE I 2000 Dresda
Cross linking: long term outcomes and
age groups P. Vinciguerra MD;
S. Trazza Orth. Istituto Clinico Humanitas
Rozzano, MI, Italy Chairman: Paolo Vinciguerra, MD
1. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross‐linking.
Vinciguerra P, Albè E, Trazza S, Rosetta P, Vinciguerra R, Seiler T, Epstein D.
Ophthalmology. 2009 Mar;116(3):369‐78.
1. Intraoperative and postoperative effects of corneal collagen cross‐linking on progressive keratoconus.
Vinciguerra P, Albè E, Trazza S, Seiler T, Epstein D.
Arch Ophthalmol. 2009 Oct;127(10):1258‐65.
Corneal Collagen Cross‐Linking for Ectasia After Excimer Laser Refractive Surgery: 1‐Year Results.
Vinciguerra P, Camesasca FI, Albè E, Trazza S.
J Refract Surg. 2009 Sep 22:1‐12.
Intra‐ and Postoperative Variation in Ocular Response Analyzer Parameters in Keratoconic Eyes After Corneal Cross‐Linking.
Vinciguerra P, Albè E, Mahmoud AM, Trazza S, Hafezi F, Roberts CJ.
J Refract Surg. 2010 Apr 28:1‐8.
Scheimpflug imaging of corneas after collagen cross‐linking.
Koller T, Iseli HP, Hafezi F, Vinciguerra P, Seiler T.
Cornea. 2009 Jun;28(5):510‐5.
Massive remodellingof the antherior corneal surface following collagen cross linking with riboflavine and UVA
Farhad Hafezi M.D., Thobiad Koller M.D.; Paolo Vinciguerra M.D, Theo Seiler, Phd, M.D.
The role of amino acids in corneal stromal healing: a method for evaluating cellular density and extracellular matrix distribution.
Torres Munoz I, Grizzi F, Russo C, Camesasca FI, Dioguardi N, Vinciguerra P.
J Refract Surg. 2003 Mar‐Apr;19(2 Suppl):S227‐30.
Use of amino acids in refractive surgery.
Vinciguerra P, Camesasca FI, Ponzin D. J
Refract Surg. 2002 May‐Jun;18(3 Suppl):S374‐7.
PHASE II 2005 Ist International Study Protocol
TRIAL CE
EUDRA CT Number
Directive 2001/20/EC N°2006‐000640‐12
Participants Number of eyes pre OP: 660 (>1000)
68 pediatric; 35 ectasic (2dmp; 5prk; 3intacs;29 lasik; 2 kr)
age@OP average 30 years (from 9 to 67)
VISUAL ACUITY 1,2
1,1
1,0
BSCVA over Time
sex female 30,53% or 210 eyes male 69,47%or 450 eyes
pre SR equiv: mean -3,79 D ± 4,216 D (from -28,58 to 5,52) pre SR sph: mean -2,44 D ± 4,02 D (from -25,67 to 6,02) pre SR cyl: mean -2,70 D ± 1,91 D (from -9,95 to 0,00)
eyes 1 y: 400 (follow up rate 47,63%) eyes 2 y: 307 (follow up rate 23,35%) eyes 3 y: 90(follow up rate 6,87%) eyes 4 y: 26 (follow up rate 1,98% eyes 5 y: 26 (follow up rate 1,98%)
0,9
0,8
0,7
0,6
0,5
0,4
0,3
0,2
0,46
0,45
0,54
0,55
0,60
0,67
0,73 0,73
D
0,60
pre op 1 m 3 m 6 m 1 y 2 y 3 y 4 y 5 y
Change in BCVA %
«SAFETY» Visual acuity Visual acuity
Spherical changed over time Astigmatism changed over time
D
D D
Sim k1 Sim k2 SRI: baseline vs follow up
SRC: baseline vs follow up SAI: baseline vs follow up Total aberration baseline vs follow up
microns
Course IC 29 – Cross-Linking – Vinciguerra - 6
Change in BSCVA Safety % Change in BSCVA Safety %
20% (9-17) 32% (18-29) 20% (30-39)
28% (9-17) 28% (>40) 23% (18-29) 28% (30-39) 21% (>40)
22% (9-17) Pediatrici 24% (18-29) 18-29 30-39 21% (30-39) >40 33% (>40)
AK ↑ AK ↑ AK ↑ AK ↓ CCT↓ CCT↓ CCT↓ CCT↑
AK ↓ AK ↓ AK ↓ AK ↓
CCT↓ CCT↓ CCT↓ CCT=
AK ↓ AK ↓ AK ↓ CCT↓ CCT↓ CCT=
Pre op Corvis
1 mos post cxl Description of parameters
Reduction of the deformation
1,20 mm 0,96 mm
5,90 ms 6,25 ms
Increased strenght
Increased reflectance
1st A length: is the cord length of the first applanation 2nd A length: is the cord length of the second applanation V in : is the corneal speed during the first applanation moment
V out : is the corneal speed during the second applanation moment W‐Dist: is the distance of the two "knee's" at the highest concavity point Curvature Rad HC: is the (central concave) curvature at the highest concavity point
Def Amp : is the maximum amplitude, so how far was the cornea shifted from the start point to the highest concavity point.
CORVIS PARAMETERS
6,00
5,00
4,00
3,00
2,00
1,00
Time CORVIS PARAMETERS second
25
20
15
10
5 0
INTRAOP RESULTS CH and CRF
0,00 1 st A lenght
2nd A lenght
V in V out W-Dist Curv Rad
HC
Def Amp 1st A-time 2st A-time HC-time
pre CXL 5,67 22,19 17,32 pre CXL 1,76 1,63 0,13 0,45 5,39 4,68 1,28 post CXL 1,73 1,50 0,11 0,39 3,17 1,00 1,35
post CXL 5,62 21,27 17,31
1st A‐time : is the time from starting until the first applanation (This delivers also the IOP‐NCT value)
p>0.05
p<0.05 p<0.05 p<0.05
2nd A‐time : is the time from starting until the second applanation
preCXL with
preCXL sine
After staining
After UVA ir
After RE-EPI
POSTOP RESULTS CH and CRF INTRAOP RESULTS Peaks POSTOP RESULTS Peak 1 and 2 AK ↑ AK ↑ AK ↓ CCT↓ CCT↓ CCT↑
p<0.05
p<0.05
PRE XL
PRE XL POST XL 1 month 6 months 12 months 24 months
p<0.05
p<0.05
p<0.05
WITH EPI Wout EPI Wout EPI POST XL POST XL POST XL POST XL preCXL preCXL After After p>0.05 p<0.05 p<0.05 p>0.05 p>0.05 p>0.05 with sine CXL RE-EPI
By age….
Loss>1
Change in BSCVA Safety %
unchanged
BSCVA:line change over time
by curvature group
By curvature group….
Spherical equivalent change over time by curvature group
Spherical change over time by curvature group
Astigmatism change over time by curvature group
ΔD ΔD ΔD
Course IC 29 – Cross-Linking – Vinciguerra - 7
Post CXL
BSCVA:line change over time by pachymetry group
Spherical change over time by thinnest point value group
ΔD
By thinnest point value group….
Astigmatism change over time by thinnest point value group
Spherical equivalent change over time by thinnest point value
group
Packing of lamellae in normals, keratoconus and after CXL
ΔD ΔD
NORMAL Kc
CXL
NORMALE Kc
CXL
Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea. Mencucci R, Marini M, Paladini I, Sarchielli E, Sgambati E, Menchini U, Vannelli GB.
Clin Experiment Ophthalmol. 2010 Jan;38(1):49-56. Lectin binding in normal, keratoconus and cross-linked human corneas.
Mencucci R, Marini M, Gheri G, Vichi D, Sarchielli E, Bonaccini L, Ambrosini S, Zappoli Thyrion GD, Paladini I, Vannelli GB, Sgambati E. Acta Histochem. 2010 Jan 4 According to Rita Mencucci, 2006
Collagen diameter increase after CXL (nm)
Transition line of keratoconus post cxl over time
in different pts
Post cxl + lac
12,2 %
4,6 %
340μ in cornea
1 yrs post cxl
292μ in cornea
2 yrs post cxl
404μ in cornea
328μ in cornea
(Wollensak,Spoerl,Seiler: Cornea 2004)
3 yrs post cxl
3,5 yrs post cxl
Deep opacity after CXL Haze post PRK
100µ Striae after cxl
296µ
Apparent corneal thinning
“Thinning” is only temporary because: Riboflavine solution contain dextrane
that together with the exposure to air of the denuded cornea dehydrates the stroma Collagen fibers and lamellae are packed
by CXL
Corneal thickness normalization Epithelium takes weeks to return to normal thickness
Stroma rehydrates
Increase of fiber diameter due to CXL
Corneal thickness can even increase with time (1‐2 years)
Pachymetry map shows a more physiological distribution with time
Reduction of the TRUE NET power of the keratoconus overtime
49.3 D 48.8 D 46.0 D 46.3 D
Pre op cxl 1 mos post cxl 3 mos post cxl 6 mos post cxl 46.8 D 46.1 D
12 mos post cxl 24 mos post cxl
pt n° 75
Differential map from pre op cxl to 2 yrs post cxl
Reduction of the area/power of the keratoconus overtime
BSCVA is better, even if curvature pattern improvement is not so big
Reduction of pachimetry map over time of the keratoconus post cxl with expansion
+3.65 D -4.15 D -6.18 D Pre cxl
0.4 -3.00 sph
1 mos post cxl
0.4 -3.00 sph
3 mos post cxl
0.4 -3.00 sph
8 mos post cx
0.9 +0.75 3.00(115) Pre cxl 1 mos post cxl 3 mos post cxl 9 mos post cxl
385µ 272µ 287µ 275µ
1°examination pre cxl 1 mos post‐
op
3 mos post
52,9 D 55,0 (+2,1) D 51,8 (-0,9) D 52,4 (-0,5) D
Differential tangential map:
0.3 +2.50 (-4.25)80 0.3 -2.00 (-5.00) 80 0.4 -1.50 (-4.50)80 0.6 -1.50 (-4.50)80
Differential pachimetry map Corneal pachymetry is
6 mos post 12 mos post 24 mos post -5.17 D -6.08 D -6.61 D
pt n° 138 Differential map from pre cxl to 24 mos post cxl
only – 0,5 D!!!
pt n° 154
pt n° 305
reduced even if is observed BSCVA gain and reduction of K values (see next)
-110 µ
Course IC 29 – Cross-Linking – Vinciguerra - 8
map
Paolo Vinciguerra M.D.
Paolo Vinciguerra M.D.
pre cxl 0,8 – 1,25@94
1 mos post cxl 0,6 +7,00 ‐1,00@90
6 mos post cxl 0,9 nat
Instantaneus map over time
Pre op 3 day post ptk+ cxl 2 mos post ptk+cxl
0,1 -7.00 (-2.00)30 0,4 -4.00 (-1,50)38 0,6 -1,50 (-
4 mos post ptk+cxl 11 mos post ptk+cxl 1,50)20
-14.46 D
0,5 -2,75(- 0,8 -1.50(- 2.00)11 2.00)20
-33.97 D
pre cxl
0,8 – 1,25@94
1 mos post cxl
0,6 +7,00 ‐1,00@90 6 mos post cxl 0,9 nat
3 mm
Pre op 2 mos post Ptk+Cxl
+ 0.575 µ + 0.100 µ
Reduction of coma aberration -0.475µ
Reduction of the area/power of the keratoconus overtime
Differential tangential map: -9.6 D
Cxl over time: from keratoconus to irregular astigmatism
Pre cxl (44,57 D) 1 mos post cxl (+1,02 D) 3 mos post cxl (-0,37 D)
Coma reduction overtime 1.685 µ 1.096 µ 1.029 µ
1.0 -2.25@7 0,9 -0,75 -2.00@20 0,9 -2,50@15 6 mos post cxl (-0,14 D) 1 yrs post cxl (-3,42 D)
Pre op cxl 1 mos post cxl 3 mos post cxl
1.079 µ 1.013 µ 0.934 µ
Differential Tangential map
from pre op to 1yrs post cxl -3,42 D
+63.5 D + +58 D (-5.4 D) +53.9(-9.6 D)
0,9 con -2,50 @15 1.0 con -2.00@10
pt n° 75
6 mos post 12 mos post cxl 24 mos post cxl
coma reduction of the 44.57 %
Differential instantaneus
BSCVA is better even if there is an apparent corneal thinning
Pre op 2 mos post Ptk+Cxl
OSV 0.6 -6.00 -1.00@120
OSV 1.0
-0.25 Look peripherical treatmant
474 µ -176 µ +94 µ
Differential instantaneus map
Pre op 3 mos post Ptk+Cxl
Zone 3 mm order 8
Pre op 3 mos post Ptk+Cxl
OSV 0.7 -1.75@11 OSV 0.7 -0.75@68
+0.575 µ +0.100 µ
-10.13 D
Paolo Vinciguerra M.D.
Course IC 29 – Cross-Linking – Vinciguerra - 9
Instantaneus map over time
Pre op 3 day post ptk+ cxl 2 mos post ptk+cxl
0,1 -7.00 (-2.00)30 0,4 -4.00 (-1,50)38 0,6 -1,50 (-1,50)20
4 mos post ptk+cxl 11 mos post ptk+cxl
-14.46 D
0,5 -2,75(-2.00)11 0,8 -1.50(-2.00)20
-33.97 D Fluctuation of aberrations over
time zone 5 order 8
Pre op 3 day post 2 mos post 4 mos post
0,1 -7.00 (-2.00)30
0,4 -4.00 (-1,50)38
0,5 -2,75(-2.00)11
0,6 -1,50 (-1,50)20
2,117 μ 1,403 μ 0,555 μ 0,349 μ Reduction of the 83,5% (‐1,768μ)
from pre op to 4 mos post ptk+ cxl
Visual acuity over time Pre op 3 day post ptk+ cxl
0,1 -7.00 (-2.00)30 0,4 -4.00 (-1,50)38 2 mos post ptk+cxl 4 mos post ptk+cxl
0,5 -2,75(-2.00)11 0,6 -1,50 (-1,50)20
III. Simoultaneous Custom Ablation and Cross-Linking
Simultaneous Custom and
CXL
Number of eyes pre OP: 9
age@OP average 35 years (from 22 to 44)
sex female 22,2% or 2 eyes male 77,8% or 7 eyes
pre SR equiv: mean -3,00 D ± 3,83 D (from -8,25 to 2,63) pre SR sph: mean -1,83 D ± 3,98 D (from -7,00 to 4,50) pre SR cyl: mean -2,33 D ± 1,70 D (from -5,00 to 0,00)
month (eyes)
60%
50%
40%
30%
20%
10%
38%
33%33%
25%
17%
25%
1
33%
50% 1
33%
13%
Paolo Vinciguerra M.D.# eyes 3 m: 6 (follow up rate 66,7%)
1 (8) 3 (6) 0 0
Silvia Trazza Orth.#
# Istituto Clinico Humanitas University of Milan , Italy
post SR equiv: mean -0,67 D ± 1,54 D (from -3,75 to 0,50) post SR sph: mean -0,04 D ± 1,47 D (from -2,75 to 1,50) post SR cyl: mean -1,25 D ± 1,30 D (from -3,50 to 0,00)
0% 9 (3) 12 (2)
Change in BSCVA - Percentage 'SAFETY'
Fluctuation of zernike ab over time
Paolo Vinciguerra M.D.
Fluctuation Wf/Corn/tot over time Change in refraction over time Patient n°1 ♂ 44 aa
Pt F:V:
Fingerprint Keratopaty + keratoconus Pre op 4 mos post ptk+ cxl
Paolo Vinciguerra M.D.
Keratoscopy over time
Pre op 3 day post ptk+ cxl
Axial map over time Pre op 3 day post ptk+ cxl
0,1 -7.00 (-2.00)30 0,4 -4.00 (-1,50)38 0,1 -7.00 (-2.00)30 0,4 -4.00 (-1,50)38
2 mos post ptk+cxl 4 mos post ptk+cxl 2 mos post ptk+cxl 4 mos post ptk+cxl
0,5 -2,75(-2.00)11 0,6 -1,50 (-1,50)20
0,5 -2,75(-2.00)11 0,6 -1,50 (-1,50)20
Fluctuation of the aberrations over time
Flucuation over time of True net power
Pre op 3 days post ptk+ cxl
2 mos post ptk+cxl
4 mos post ptk+cxl
10 mos post ptk+cxl
Pre op 3 day post ptk+ cxl
2 mos post ptk+cxl
4 mos post ptk+cxl
1,283μ 0,935μ 0,673μ 0,482μ 0,415μ
0,1 -7.00 (-2.00)30
0,4 -4.00 (-1,50)38
0,5 -2,75(-2.00)11
0,6 -2,75(-2.00)11
0,8 -1.50(-2.00)20
0,1 -7.00 (-
0,4 -4.00 0,5 -
0,6 -1,50
2.00)30 (-1,50)38 2,75(-2.00)11 (-1,50)20
Differential true net power : -7,50 D
Fluctuation over time of pachimetry map Zonal refraction over time Pre op 3 day post ptk+ cxl
Pre op 3 day post ptk+ cxl
2 mos post ptk+cxl
4 mos post ptk+cxl
0,1 -7.00 (-2.00)30
0,4 -4.00 (-1,50)38
0,5 - 2,75(-2.00)11
0,6 -1,50 (-1,50)20
2 mos post ptk+cxl 4 mos post ptk+cxl
Differential pachimetry map: -128 micron From pre op to 4 mos post ptk + cxl
Course IC 72 – Cross-Linking – Vinciguerra - 10
3 mm
Pre op 2 mos post Ptk+Cxl
+ 0.575 µ + 0.100 µ
Reduction of coma aberration -0.475µ
Patient n°2 ♂ 34 aa
Pt F.G. Differential instantaneus map Pre op 2 mos post Ptk+Cxl
Esiti PRK OO 1999 (pre op ODV 1.0 -3.00 -0.25@90
OSV 0.9 -7.00 Ptk+CXL 11/12/2009
OSV pre 0.6 -6.00 -1.00@120 OSV 1 mos 1.0 -0.25
OSV 0.6 -6.00 -1.00@120
OSV 1.0 -0.25
Look at peripheral treatment
Elevation front map Pre op 2 mos post Ptk+Cxl
Differential elevation front map
Pre op 2 mos post Ptk+Cxl
Pre op 2 mos post Ptk+Cxl
Differential Pachymetry map
Pachymetry map:
-183µ
Advanced KC ODV: 0.1 -14.00 (-3.00) 45
Advanced KC
Oct SA custom + cxl 1 mos post
68µ
240 µ
492 µ
400µ
360 µ
204 µ
Patient n°3 ♂ 37 aa
Keratoconus diagnosed in 2006. No CL Ptk+Cxl 14/12/2009
OSV pre 0.7 (-1.75)@11 OSV pre 0.7 (-0.75)@68
Differential instantaneus map
Pre op 3 mos post Ptk+Cxl
OSV 0.7 -1.75@11 OSV 0.7 -0.75@68
Pre op 3 mos post Ptk+Cxl
Improved ring
regularity
OSV 0.7 -1.75@11 OSV 0.7 -0.75@68
-10.13 D
Zone 3 mm order 8 Zone 6 mm order 8
Pre op 3 mos post Ptk+Cxl
Pre op 3 mos post Ptk+Cxl
Pre op 3 mos post Ptk+Cxl
+0.575 µ +0.100 µ +3.346 µ +1.175 µ
Course IC 72 – Cross-Linking – Vinciguerra - 11
Paolo Vinciguerra M.D.
Paolo Vinciguerra M.D. Paolo Vinciguerra M.D.
Paolo Vinciguerra M.D.
Paolo Vinciguerra M.D.
Zone 8 mm order 8
Pre op 3 mos post Ptk+Cxl
Change in true net map over time
Pre op
+5.637 µ +3.848µ
1 mos post custom+cxl
Difference From preop to 6 mos post custom+cxl
6 mos post custom+cxl
Paolo Vinciguerra M.D.
Paolo Vinciguerra M.D.
Pre op 1 mos post custom+ cxl
Reduction of the deformation
Change in Belin indices & keratometric Power Deviation
Change in elevation anterior map over time
Increased strenght
Increased reflectance
Difference From preop to 6 mos post custom+cxl
Paolo Vinciguerra M.D.
Paolo Vinciguerra M.D.
Change in elevation posterior map over time
Difference From preop to 6 mos post custom+cxl
Paolo Vinciguerra M.D.
Paolo Vinciguerra M.D.
Paolo Vinciguerra M.D.
Course IC 72 – Cross-Linking – Vinciguerra - 12
Addresses
Paolo Vinciguerra, MD Chairman, Ophthalmology Dept. Istituto Clinico Humanitas Office: Via Ripamonti, 205 - 20100 Milano - Italy Ph + 39 02 55211388 - Fax +39 02 57410355 [email protected] - www.paolovinciguerra.com - www.refractiveonline.it
Fabrizio I. Camesasca, MD Ophthalmology Dept. Istituto Clinico Humanitas Office: P.za Maria Adelaide, 1 - 20129 Milano - Italy Ph +39 02 29529396 - Fax +39 02 29529396 [email protected] - www.camesasca.com
Jorge L. Alio Vissum Instituto Oftalmologico de Alicante Avenida de Denia s/n Edificio Vissum 03016 Alicante - Spain [email protected]